Davis J. E. 4

What Happened
Davis J. E., CEO, President and Director of Quest Diagnostics (DGX), was issued 51,652 shares on 2026-03-04 in settlement of a performance stock award (acquisition code A) valued at $10,581,429 (51,652 × $204.86). On the same date 26,414 shares were surrendered back to the issuer to satisfy tax withholding obligations (disposition code F) totaling $5,411,172 (26,414 × $204.86).

Key Details

• Transaction dates: 2026-03-04 (reported on Form 4 filed 2026-03-06). Filing appears timely.
• Award: 51,652 shares @ $204.86 each = $10,581,429 (code A).
• Tax withholding/Disposition: 26,414 shares @ $204.86 each = $5,411,172 (code F).
• Footnotes: F1 — stock issued in settlement of a performance stock award in accordance with Rule 16b-3(d). F2 — shares disposed to issuer solely to cover tax withholding from the award.
• Shares owned after the transaction: not disclosed in the provided filing.

Context
This was a stock award settlement (not an open-market purchase or sale). The surrender of shares to the issuer to cover taxes is a routine cashless/withholding transaction and does not necessarily indicate a change in the insider’s view of the company.